Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 101

    Lupin launches Lanthanum Carbonate chewable tablets in US

    Lupin launches Lanthanum Carbonate chewable tablets in US

    Ruby Khatun Khatun2 Sept 2017 10:33 AM IST
    New Delhi: Drug firm Lupin on Thursday said it has launched generic Lanthanum Carbonate chewable tablets used for reducing serum phosphate in patients...
    SC restrains Singh brothers from diluting any stake in Fortis Healthcare

    SC restrains Singh brothers from diluting any stake in Fortis Healthcare

    Ruby Khatun Khatun1 Sept 2017 3:54 PM IST
    New Delhi: The Supreme Court on Thursday restrained brothers Malvinder Singh and Shivinder Singh from diluting any stake in the Fortis Healthcare.The...
    Arrow Pharma acquires Australian operations of Amneal Pharma

    Arrow Pharma acquires Australian operations of Amneal Pharma

    Ruby Khatun Khatun1 Sept 2017 1:38 PM IST
    New Delhi: Drug firm Strides Shasun said its arm Arrow Pharmaceuticals has acquired Australian operations of Amneal Pharmaceuticals for a total...
    US clears first LIVING DRUG, developed by Novartis for leukemia treatment, cost- 475,000 dollar

    US clears first LIVING DRUG, developed by Novartis for leukemia treatment, cost- 475,000 dollar

    Ruby Khatun Khatun31 Aug 2017 11:00 AM IST
    Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients’ own...
    FDA approves first US treatment for Chagas disease

    FDA approves first US treatment for Chagas disease

    savita thakur thakur31 Aug 2017 9:30 AM IST
    The U.S. Food and Drug Administration granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It...
    USFDA hikes fee for processing New Drug Application by 1 lakh dollar for FY18

    USFDA hikes fee for processing New Drug Application by 1 lakh dollar for FY18

    savita thakur thakur30 Aug 2017 12:37 PM IST
    HYDERABAD: Citing high workload, the US Food and Drug Administration (USFDA) has increased fee for processing Abbreviated New Drug Application (ANDA)...
    Zydus Cadila gets EIR from USFDA for Pharma SEZ plant at Ahmedabad

    Zydus Cadila gets EIR from USFDA for Pharma SEZ plant at Ahmedabad

    savita thakur thakur30 Aug 2017 12:35 PM IST
    NEW DELHI: Drug firm Zydus Cadila said it has received establishment inspection report from the US health regulator for its manufacturing facility at...
    DoP accepts Sun Pharmas review petition on fixing price of Volitra Enzo Tablet

    DoP accepts Sun Pharmas review petition on fixing price of Volitra Enzo Tablet

    Ruby Khatun Khatun29 Aug 2017 9:45 AM IST
    The Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical’s review petition against price fixation of “Volitra Enzo Tablet” containing...
    Class action lawsuit filed against Dr Reddy’s Laboratories in US

    Class action lawsuit filed against Dr Reddy’s Laboratories in US

    savita thakur thakur29 Aug 2017 9:30 AM IST
    NEW DELHI: Drug firm Dr Reddy's Laboratories said a class action lawsuit has been filed against it in the US by an investor alleging misleading...
    Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance

    Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance

    Ruby Khatun Khatun28 Aug 2017 4:33 PM IST
    New Delhi: Maharashtra FDA had carried out 2,540 inspections on 2,493 manufacturing units across the state since April 2016 till date and on the basis...
    Kiran Mazumdar Shaw to lead Infy CEO search, may go back to alumni

    Kiran Mazumdar Shaw to lead Infy CEO search, may go back to alumni

    Ruby Khatun Khatun27 Aug 2017 10:30 AM IST
    New Delhi: Former Infoscions may well have a shot at clinching the top job as Infosys CEO, with the company looking at "alumni" along with internal...
    DoP invites nominations for 3rd India Pharma and Medical Device Awards

    DoP invites nominations for 3rd India Pharma and Medical Device Awards

    Ruby Khatun Khatun27 Aug 2017 9:04 AM IST
    New Delhi: Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals has decided to confer 3rd India Pharma and...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok